ANAVEX LIFE SCIENCES CORP. Research and Development Expense
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Research and Development Expense of $4.19 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-08-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. research and development expense for the quarter ending 2026-03-31 was $4.19M, a 57.62% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. research and development expense for the quarter ending 2025-12-31 was $4.66M, a 55.43% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. research and development expense for the quarter ending 2025-09-30 was $7.29M, a 37.20% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. research and development expense for the quarter ending 2025-06-30 was $9.96M, a 15.68% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. research and development expense for fiscal 2025 was $37.59M, a 10.15% decline from fiscal 2024.
- ANAVEX LIFE SCIENCES CORP. research and development expense for fiscal 2024 was $41.84M, a 4.30% decline from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. research and development expense for fiscal 2023 was $43.72M, a 15.30% increase from fiscal 2022.
- ANAVEX LIFE SCIENCES CORP. research and development expense for fiscal 2022 was $37.92M, a 14.95% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 89 month | Research and Development Expense 92 month | Research and Development Expense 95 month | Research and Development Expense 98 month | Research and Development Expense 101 month | Research and Development Expense 104 month | Research and Development Expense 107 month | Research and Development Expense 110 month | Research and Development Expense 113 month | Research and Development Expense 116 month | Research and Development Expense 119 month | Research and Development Expense 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $4.19M 10-Q · filed 2026-08-28 | $8.85M 10-Q · filed 2026-08-28 | $16.14M derived: sum of 3 quarters · filed 2026-08-28 | $26.10M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2025-12-31 | $4.66M 10-Q · filed 2026-02-09 | $11.95M derived: sum of 2 quarters · filed 2026-08-28 | $21.91M derived: sum of 3 quarters · filed 2026-08-28 | $31.80M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2025-09-30 | $7.29M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $17.25M derived: sum of 2 quarters · filed 2026-08-28 | $27.14M derived: sum of 3 quarters · filed 2026-08-28 | $37.59M 10-K/A · filed 2026-08-28 | ||||||||||||||||
| 2025-06-30 | $9.96M 10-Q · filed 2025-08-12 | $19.85M derived: sum of 2 quarters · filed 2026-08-28 | $30.30M 10-Q · filed 2025-08-12 | $41.91M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2025-03-31 | $9.89M 10-Q · filed 2026-08-28 | $20.34M 10-Q · filed 2026-08-28 | $31.95M derived: sum of 3 quarters · filed 2026-08-28 | $43.76M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2024-12-31 | $10.45M 10-Q · filed 2026-02-09 | $22.06M derived: sum of 2 quarters · filed 2026-08-28 | $33.87M derived: sum of 3 quarters · filed 2026-08-28 | $43.60M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2024-09-30 | $11.61M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $23.43M derived: sum of 2 quarters · filed 2026-08-28 | $33.15M derived: sum of 3 quarters · filed 2026-08-28 | $41.84M 10-K/A · filed 2026-08-28 | ||||||||||||||||
| 2024-06-30 | $11.81M 10-Q · filed 2025-08-12 | $11.87M 10-Q · filed 2024-08-06 | $21.54M derived: sum of 2 quarters · filed 2025-08-12 | $30.22M 10-Q · filed 2025-08-12 | $30.28M 10-Q · filed 2024-08-06 | $40.28M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||
| 2024-03-31 | $9.73M 10-Q · filed 2025-05-13 | $18.41M 10-Q · filed 2025-05-13 | $28.47M derived: sum of 3 quarters · filed 2026-08-28 | $38.76M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2023-12-31 | $8.68M 10-Q · filed 2025-02-12 | $18.74M derived: sum of 2 quarters · filed 2026-08-28 | $29.03M derived: sum of 3 quarters · filed 2026-08-28 | $40.33M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2023-09-30 | $10.06M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $20.34M derived: sum of 2 quarters · filed 2026-08-28 | $31.65M derived: sum of 3 quarters · filed 2026-08-28 | $43.72M 10-K/A · filed 2026-08-28 | ||||||||||||||||
| 2023-06-30 | $10.28M 10-Q · filed 2024-08-06 | $10.28M 10-Q · filed 2023-08-08 | $21.59M derived: sum of 2 quarters · filed 2024-08-06 | $33.66M 10-Q · filed 2024-08-06 | $33.66M 10-Q · filed 2023-08-08 | $45.04M derived: sum of 4 quarters · filed 2024-08-06 | ||||||||||||||
| 2023-03-31 | $11.31M 10-Q · filed 2024-05-09 | $11.31M 10-Q · filed 2023-05-09 | $23.37M 10-Q · filed 2024-05-09 | $23.37M 10-Q · filed 2023-05-09 | $34.76M derived: sum of 3 quarters · filed 2024-05-09 | $44.03M derived: sum of 4 quarters · filed 2024-05-09 | ||||||||||||||
| 2022-12-31 | $12.07M 10-Q · filed 2024-02-07 | $12.07M 10-Q · filed 2023-02-07 | $23.45M derived: sum of 2 quarters · filed 2024-02-07 | $32.72M derived: sum of 3 quarters · filed 2024-02-07 | $41.33M derived: sum of 4 quarters · filed 2024-02-07 | |||||||||||||||
| 2022-09-30 | $11.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $20.65M derived: sum of 2 quarters · filed 2023-11-27 | $29.26M derived: sum of 3 quarters · filed 2023-11-27 | $37.92M 10-K · filed 2023-11-27 | $37.92M 10-K · filed 2022-11-28 | |||||||||||||||
| 2022-06-30 | $9.27M 10-Q · filed 2023-08-08 | $17.88M derived: sum of 2 quarters · filed 2023-08-08 | $26.53M 10-Q · filed 2023-08-08 | $35.91M derived: sum of 4 quarters · filed 2023-11-27 | ||||||||||||||||
| 2022-03-31 | $8.60M 10-Q · filed 2023-05-09 | $17.26M 10-Q · filed 2023-05-09 | $26.63M derived: sum of 3 quarters · filed 2023-11-27 | $35.60M derived: sum of 4 quarters · filed 2023-11-27 | ||||||||||||||||
| 2021-12-31 | $8.66M 10-Q · filed 2023-02-07 | $18.03M derived: sum of 2 quarters · filed 2023-11-27 | $26.99M derived: sum of 3 quarters · filed 2023-11-27 | $33.71M derived: sum of 4 quarters · filed 2023-11-27 | ||||||||||||||||
| 2021-09-30 | $9.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $18.34M derived: sum of 2 quarters · filed 2023-11-27 | $25.06M derived: sum of 3 quarters · filed 2023-11-27 | $32.98M 10-K · filed 2023-11-27 | $32.98M 10-K · filed 2021-11-24 | |||||||||||||||
| 2021-06-30 | $8.96M 10-Q · filed 2022-08-09 | $15.69M derived: sum of 2 quarters · filed 2022-08-09 | $23.61M 10-Q · filed 2022-08-09 | $29.72M derived: sum of 4 quarters · filed 2022-11-28 | ||||||||||||||||
| 2021-03-31 | $6.72M 10-Q · filed 2022-05-10 | $14.65M 10-Q · filed 2022-05-10 | $20.75M derived: sum of 3 quarters · filed 2022-11-28 | $27.48M derived: sum of 4 quarters · filed 2022-11-28 | ||||||||||||||||
| 2020-12-31 | $7.93M 10-Q · filed 2022-02-09 | $14.03M derived: sum of 2 quarters · filed 2022-11-28 | $20.76M derived: sum of 3 quarters · filed 2022-11-28 | $26.81M derived: sum of 4 quarters · filed 2022-11-28 | ||||||||||||||||
| 2020-09-30 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $12.83M derived: sum of 2 quarters · filed 2022-11-28 | $18.88M derived: sum of 3 quarters · filed 2022-11-28 | $25.23M 10-K · filed 2022-11-28 | ||||||||||||||||
| 2020-06-30 | $6.73M 10-Q · filed 2021-08-12 | $12.78M derived: sum of 2 quarters · filed 2021-08-12 | $19.13M 10-Q · filed 2021-08-12 | $23.84M derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||||||||
| 2020-03-31 | $6.05M 10-Q · filed 2021-05-13 | $12.40M 10-Q · filed 2021-05-13 | $17.11M derived: sum of 3 quarters · filed 2021-05-13 | $22.87M derived: sum of 4 quarters · filed 2021-05-13 | ||||||||||||||||
| 2019-12-31 | $6.35M 10-Q · filed 2021-02-16 | $11.06M derived: sum of 2 quarters · filed 2021-02-16 | $16.82M derived: sum of 3 quarters · filed 2021-02-16 | $22.90M derived: sum of 4 quarters · filed 2021-02-16 | ||||||||||||||||
| 2019-09-30 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $10.47M derived: sum of 2 quarters · filed 2020-12-28 | $16.55M derived: sum of 3 quarters · filed 2020-12-28 | $22.26M 10-K · filed 2020-12-28 | ||||||||||||||||
| 2019-06-30 | $5.76M 10-Q · filed 2020-08-06 | $11.84M derived: sum of 2 quarters · filed 2020-08-06 | $17.55M 10-Q · filed 2020-08-06 | $21.96M derived: sum of 4 quarters · filed 2020-08-06 | ||||||||||||||||
| 2019-03-31 | $6.08M 10-Q · filed 2020-05-07 | $11.79M 10-Q · filed 2020-05-07 | $16.20M derived: sum of 3 quarters · filed 2020-05-07 | $19.20M derived: sum of 4 quarters · filed 2020-05-07 | ||||||||||||||||
| 2018-12-31 | $5.71M 10-Q · filed 2020-02-06 | $10.12M derived: sum of 2 quarters · filed 2020-02-06 | $13.12M derived: sum of 3 quarters · filed 2020-02-06 | $16.36M derived: sum of 4 quarters · filed 2020-02-06 | ||||||||||||||||
| 2018-09-30 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $7.41M derived: sum of 2 quarters · filed 2019-12-16 | $10.65M derived: sum of 3 quarters · filed 2019-12-16 | $13.34M 10-K · filed 2019-12-16 | ||||||||||||||||
| 2018-06-30 | $3.00M 10-Q · filed 2019-08-07 | $6.24M derived: sum of 2 quarters · filed 2019-08-07 | $8.94M 10-Q · filed 2019-08-07 | $12.77M derived: sum of 4 quarters · filed 2019-08-07 | ||||||||||||||||
| 2018-03-31 | $3.25M 10-Q · filed 2019-05-09 | $5.94M 10-Q · filed 2019-05-09 | $9.78M derived: sum of 3 quarters · filed 2019-05-09 | $12.08M derived: sum of 4 quarters · filed 2019-05-09 | ||||||||||||||||
| 2017-12-31 | $2.69M 10-Q · filed 2019-02-07 | $6.53M derived: sum of 2 quarters · filed 2019-02-07 | $8.83M derived: sum of 3 quarters · filed 2019-02-07 | $11.32M derived: sum of 4 quarters · filed 2019-02-07 | ||||||||||||||||
| 2017-09-30 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $6.14M derived: sum of 2 quarters · filed 2019-01-25 | $8.63M derived: sum of 3 quarters · filed 2019-01-25 | $10.67M 10-K · filed 2019-01-25 | ||||||||||||||||
| 2017-06-30 | $2.30M 10-Q · filed 2018-08-09 | $4.79M derived: sum of 2 quarters · filed 2018-08-09 | $6.84M 10-Q · filed 2018-08-09 | $10.20M derived: sum of 4 quarters · filed 2019-01-25 | ||||||||||||||||
| 2017-03-31 | $2.49M 10-Q · filed 2018-05-10 | $4.54M 10-Q · filed 2018-05-10 | $7.90M derived: sum of 3 quarters · filed 2019-01-25 | $9.06M derived: sum of 4 quarters · filed 2019-01-25 | ||||||||||||||||
| 2016-12-31 | $2.04M 10-Q · filed 2018-02-07 | $5.41M derived: sum of 2 quarters · filed 2019-01-25 | $6.57M derived: sum of 3 quarters · filed 2019-01-25 | $7.66M derived: sum of 4 quarters · filed 2019-01-25 | ||||||||||||||||
| 2016-09-30 | $3.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $4.52M derived: sum of 2 quarters · filed 2019-01-25 | $5.61M derived: sum of 3 quarters · filed 2019-01-25 | $7.25M 10-K · filed 2019-01-25 | ||||||||||||||||
| 2016-06-30 | $1.16M 10-Q · filed 2017-08-07 | $917.30K 10-Q · filed 2016-08-11 | $2.25M derived: sum of 2 quarters · filed 2017-08-07 | $3.89M 10-Q · filed 2017-08-07 | $2.92M 10-Q · filed 2016-08-11 | $4.16M derived: sum of 4 quarters · filed 2017-12-11 | ||||||||||||||
| 2016-03-31 | $1.09M 10-Q · filed 2017-05-10 | $1.33M 10-Q · filed 2016-05-11 | $2.73M 10-Q · filed 2017-05-10 | $2.00M 10-Q · filed 2016-05-11 | $3.00M derived: sum of 3 quarters · filed 2017-12-11 | $3.80M derived: sum of 4 quarters · filed 2017-12-11 | ||||||||||||||
| 2015-12-31 | $1.16M 10-Q · filed 2017-02-07 | $670.74K 10-Q · filed 2016-02-08 | $1.91M derived: sum of 2 quarters · filed 2017-12-11 | $2.71M derived: sum of 3 quarters · filed 2017-12-11 | $3.12M derived: sum of 4 quarters · filed 2017-12-11 | |||||||||||||||
| 2015-09-30 | $746.50K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $1.55M derived: sum of 2 quarters · filed 2017-12-11 | $1.95M derived: sum of 3 quarters · filed 2017-12-11 | $2.27M 10-K · filed 2017-12-11 | ||||||||||||||||
| 2015-06-30 | $799.46K 10-Q · filed 2016-08-11 | $1.21M derived: sum of 2 quarters · filed 2016-08-11 | $1.53M 10-Q · filed 2016-08-11 | $1.87M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||||||
| 2015-03-31 | $407.15K 10-Q · filed 2016-05-11 | $725.77K 10-Q · filed 2016-05-11 | $1.07M derived: sum of 3 quarters · filed 2016-12-14 | $1.33M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||||||
| 2014-12-31 | $318.63K 10-Q · filed 2016-02-08 | $662.67K derived: sum of 2 quarters · filed 2016-12-14 | $927.69K derived: sum of 3 quarters · filed 2016-12-14 | $1.05M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||||||
| 2014-09-30 | $344.05K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | $609.06K derived: sum of 2 quarters · filed 2016-12-14 | $727.22K derived: sum of 3 quarters · filed 2016-12-14 | $732.39K 10-K · filed 2016-12-14 | ||||||||||||||||
| 2014-06-30 | $265.01K 10-Q · filed 2015-08-14 | $383.17K derived: sum of 2 quarters · filed 2015-08-14 | $388.35K 10-Q · filed 2015-08-14 | $485.61K derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||||||
| 2014-03-31 | $118.15K 10-Q · filed 2015-05-14 | $123.33K 10-Q · filed 2015-05-14 | $220.59K derived: sum of 3 quarters · filed 2015-05-14 | $259.62K derived: sum of 4 quarters · filed 2015-05-14 | $12.95M 10-Q/A · filed 2014-05-30 | |||||||||||||||
| 2013-12-31 | $5.18K 10-Q · filed 2015-02-17 | $102.44K derived: sum of 2 quarters · filed 2015-02-17 | $141.46K derived: sum of 3 quarters · filed 2015-02-17 | $142.02K derived: sum of 4 quarters · filed 2015-02-17 | $12.83M 10-Q · filed 2014-02-14 | |||||||||||||||
| 2013-09-30 | $97.26K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | $136.28K derived: sum of 2 quarters · filed 2014-12-29 | $136.84K derived: sum of 3 quarters · filed 2014-12-29 | $263.85K 10-K · filed 2014-12-29 | $12.82M 10-K · filed 2013-12-30 | |||||||||||||||
| 2013-06-30 | $39.02K 10-Q · filed 2014-08-13 | $39.58K derived: sum of 2 quarters · filed 2014-08-13 | $166.58K 10-Q · filed 2014-08-13 | $279.54K derived: sum of 4 quarters · filed 2014-08-13 | $12.73M 10-Q · filed 2013-08-14 | |||||||||||||||
| 2013-03-31 | $560.00 10-Q/A · filed 2014-05-30 | $127.56K 10-Q/A · filed 2014-05-30 | $240.52K derived: sum of 3 quarters · filed 2014-05-30 | $634.48K derived: sum of 4 quarters · filed 2014-05-30 | $12.69M 10-Q · filed 2013-05-17 | |||||||||||||||
| 2012-12-31 | $127.00K 10-Q · filed 2014-02-14 | $239.96K derived: sum of 2 quarters · filed 2014-02-14 | $633.92K derived: sum of 3 quarters · filed 2014-02-14 | $1.06M derived: sum of 4 quarters · filed 2014-02-14 | $12.69M 10-Q · filed 2013-02-14 | |||||||||||||||
| 2012-09-30 | $112.96K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $506.92K derived: sum of 2 quarters · filed 2013-12-30 | $936.53K derived: sum of 3 quarters · filed 2013-12-30 | $2.65M 10-K · filed 2013-12-30 | $12.56M 10-K · filed 2012-12-31 | |||||||||||||||
| 2012-06-30 | $393.96K 10-Q · filed 2013-08-14 | $823.57K derived: sum of 2 quarters · filed 2013-08-14 | $2.54M 10-Q · filed 2013-08-14 | $3.13M derived: sum of 4 quarters · filed 2013-08-14 | $12.45M 10-Q · filed 2012-08-17 | |||||||||||||||
| 2012-03-31 | $429.61K 10-Q · filed 2013-05-17 | $2.15M 10-Q · filed 2013-05-17 | $2.74M derived: sum of 3 quarters · filed 2013-05-17 | $3.52M derived: sum of 4 quarters · filed 2013-05-17 | $12.05M 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | $1.72M 10-Q · filed 2013-02-14 | $2.31M derived: sum of 2 quarters · filed 2013-02-14 | $3.09M derived: sum of 3 quarters · filed 2013-02-14 | $3.82M derived: sum of 4 quarters · filed 2013-02-14 | $11.62M 10-Q · filed 2012-02-14 | |||||||||||||||
| 2011-09-30 | $591.78K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | $1.37M derived: sum of 2 quarters · filed 2012-12-31 | $2.10M derived: sum of 3 quarters · filed 2012-12-31 | $2.60M 10-K · filed 2012-12-31 | $9.91M 10-K · filed 2011-12-22 | |||||||||||||||
| 2011-06-30 | $777.97K 10-Q · filed 2012-08-17 | $1.51M derived: sum of 2 quarters · filed 2012-08-17 | $2.01M 10-Q · filed 2012-08-17 | $3.09M derived: sum of 4 quarters · filed 2012-08-17 | $9.31M 10-Q · filed 2011-08-12 | |||||||||||||||
| 2011-03-31 | $730.24K 10-Q · filed 2012-05-15 | $1.23M 10-Q · filed 2012-05-15 | $2.32M derived: sum of 3 quarters · filed 2012-05-15 | $2.93M derived: sum of 4 quarters · filed 2012-05-15 | ||||||||||||||||
| 2010-12-31 | $497.29K 10-Q · filed 2012-02-14 | $1.59M derived: sum of 2 quarters · filed 2012-02-14 | $2.20M derived: sum of 3 quarters · filed 2012-02-14 | |||||||||||||||||
| 2010-09-30 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-22 | $1.70M derived: sum of 2 quarters · filed 2011-12-22 | $2.73M 10-K · filed 2011-12-22 | |||||||||||||||||
| 2010-06-30 | $613.16K 10-Q · filed 2011-08-12 | $1.64M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |